Skip to main content

Table 2 Overall and type-specific prevalence of HPV infection, 2015–2019

From: Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China

HPV genotype

Positive cases

Percentage for all sample (%)

95% CI for all samples (%)

2015 (n = 252)

2016 (n = 1900)

2017 (n = 2728)

2018 (n = 5907)

2019 (n = 13,079)

χ2

P

gamma value

Any HPV

4489

18.81

(18.31–19.30)

142 (56.35%)

472 (24.84%)

582 (21.33%)

1009 (17.08%)

2284 (17.46%)

155.025

< 0.001

− 0.125

HR HPV

2781

11.65

(11.24–12.06)

73 (28.97%)

283 (14.89%)

370 (13.56%)

657 (11.12%)

1398 (10.69%)

74.789

< 0.001

− 0.115

HPV-16

559

2.34

(2.15–2.53)

17 (6.75%)

62 (3.26%)

87 (3.19%)

139 (2.35%)

254 (1.94%)

37.216

< 0.001

− 0.185

HPV-18

239

1.00

(0.87–1.12)

6 (2.38%)

33 (1.74%)

23 (0.84%)

65 (1.10%)

112 (0.86%)

11.689

0.001

− 0.152

HPV-26

13

0.05

(0.02–0.08)

0 (0.0%)

3 (0.16%)

1 (0.04%)

3 (0.05%)

6 (0.05%)

1.308

0.253

− 0.200

HPV-31

82

0.34

(0.26–0.41)

3 (1.19%)

7 (0.37%)

7 (0.26%)

15 (0.25%)

50 (0.38%)

0.992

< 0.001

0.066

HPV-33

149

0.62

(0.52–0.72)

12 (4.76%)

20 (1.05%)

19 (0.70%)

42 (0.71%)

56 (0.43%)

37.537

< 0.001

− 0.313

HPV-35

119

0.50

(0.40–0.58)

9 (3.57%)

13 (0.68%)

22 (0.81%)

26 (0.44%)

49 (0.37%)

25.027

< 0.001

− 0.281

HPV-39

324

1.36

(1.21–1.50)

10 (3.97%)

44 (2.32%)

48 (1.76%)

69 (1.17)

153 (1.17%)

25.858

< 0.001

− 0.180

HPV-45

80

0.34

(0.26–0.40)

2 (0.79%)

10 (0.53%)

14 (0.51%)

13 (0.22%)

41 (0.31%)

4.187

0.041

− 0.131

HPV-51

273

1.14

(1.00–1.27)

14 (5.56%)

35 (1.84%)

37 (1.36%)

58 (0.98%)

129 (0.99%)

27.131

< 0.001

− 0.185

HPV-52

705

2.95

(2.73–3.16)

30 (11.90%)

69 (3.63%)

91 (3.34%)

151 (2.56%)

364 (2.78%)

22.886

< 0.001

− 0.099

HPV-53

399

1.67

(1.50–1.83)

11 (4.37%)

42 (2.21%)

54 (1.98%)

95 (1.61%)

197 (1.51%)

12.594

< 0.001

− 0.120

HPV-56

308

1.29

(1.14–1.43)

10 (3.97%)

31 (1.63%)

33 (1.21%)

73 (1.24%)

161 (1.23%)

4.866

0.027

− 0.069

HPV-58

495

2.07

(1.89–2.25)

22 (8.73%)

52 (2.74%)

65 (2.38%)

116 (1.96%)

240 (1.84%)

26.920

< 0.001

− 0.145

HPV-59

257

1.08

(0.94–1.20)

7 (2.78%)

42 (2.21%)

35 (1.28%)

46 (0.78%)

127 (0.97%)

21.993

< 0.001

− 0.167

HPV-66

209

0.88

(0.75–0.99)

11 (4.37%)

17 (0.89%)

27 (0.99%)

47 (0.80%)

107 (0.82%)

6.964

0.009

− 0.098

HPV-68

132

0.55

(0.45–0.64)

1 (0.40%)

6 (0.32%)

10 (0.37%)

32 (0.54%)

83 (0.63%)

5.044

0.025

0.171

HPV-82

92

0.39

(0.30-.46)

6 (2.38%)

16 (0.84%)

7 (0.26%)

18 (0.30%)

45 (0.34%)

12.653

< 0.001

− 0.184

HR + LR

707

2.96

(2.74–3.17)

42 (16.67%)

87 (4.58%)

85 (3.12%)

154 (2.61%)

339 (2.59%)

67.915

< 0.001

− 0.176

LR HPV

1001

4.19

(3.94–4.44)

27 (10.71%)

102 (5.37%)

127 (4.66%)

198 (3.35%)

547 (4.18%)

11.973

0.001

− 0.048

HPV-6

309

1.29

(1.15–1.43)

29 (11.51%)

44 (2.32%)

51 (1.87%)

52 (0.88%)

133 (1.02%)

91.034

< 0.001

− 0.294

HPV-11

194

0.81

(0.69–0.92)

18 (7.14%)

30 (1.58%)

25 (0.92%)

38 (0.64%)

83 (0.63%)

54.330

< 0.001

− 0.286

HPV-40

39

0.16

(0.11–0.21)

3 (1.19%)

6 (0.32%)

6 (0.22%)

10 (0.17%)

14 (0.11%)

12.752

< 0.001

− 0.351

HPV-42

84

0.35

(0.27–0.42)

0 (0.00%)

12 (0.63%)

9 (0.33%)

14 (0.24%)

49 (0.37%)

0.227

0.634

0.004

HPV-43

265

1.11

(0.97–1.24)

8 (3.17%)

27 (1.42%)

37 (1.36%)

68 (1.15%)

125 ().96%)

11.083

0.001

− 0.147

HPV-44

205

0.86

(0.74–0.97)

4

15

22

46

118

0.086

0.769

0.037

    

(1.59%)

(0.79%)

(0.81%)

(0.78%)

(0.90%)

   

HPV-55

209

0.88

(0.75–0.99)

12 (4.76%)

20 (1.05%)

38 (1.39%)

31 (0.52%)

108 (0.83%)

15.286

< 0.001

− 0.137

HPV-61

362

1.52

(1.36–1.67)

8 (3.17%)

30 (1.58%)

36 (1.32%)

75 (1.27%)

213 (1.63%)

0.072

0.789

0.047

HPV-81

285

1.19

(1.05–1.33)

8 (3.17%)

22 (1.16%)

37 (1.36)

71 (1.20%)

147 (1.12%)

2.584

0.108

− 0.066

HPV-83

48

0.20

(0.14–0.25)

1 (0.4%)

6 (0.32%)

6 (0.22%)

9 (0.15%)

26 (0.20%)

0.909

0.340

− 0.065